Mosquito News and Research

RSS

Inovio announces positive results on DNA-based monoclonal antibody therapy targeting CHIKV

Inovio Pharmaceuticals, Inc. announced today that its novel DNA-based therapeutic monoclonal antibody targeting Chikungunya virus (CHIKV) completely protected mice from a lethal CHIKV challenge.

27 May 2014

Researchers uncover potential vaccine that can stop malaria parasites from multiplying

Researchers have identified a substance, or antigen, that generates antibodies that can hinder the ability of malaria parasites to multiply, which may protect against severe malaria infection.

23 May 2014

NIH-funded study in tanzanian infants tracked risk of severe malaria over time

Although malaria kills some 600,000 African children each year, most cases of the mosquito-borne parasitic disease in children are mild.

8 May 2014

Biotech to the rescue

MIT professor Ram Sasisekharan's three biotech companies — Momenta Pharmaceuticals, Cerulean Pharma, and Visterra — share a similar goal.

1 May 2014

Johns Hopkins hosts World Malaria Day to combat malaria in Africa

Johns Hopkins Bloomberg School of Public Health is bringing together some of the best minds in academia, government and faith-based organizations on World Malaria Day, Friday, April 25, 2014, for a day of discussion on leveraging community involvement to combat malaria in Africa.

25 Apr 2014

Findings could revive use of chloroquine drug in treating, preventing mosquito-bourne disease

An anti-malarial treatment that lost its status as the leading weapon against the deadly disease could be given a new lease of life, with new research indicating it simply needs to be administered differently.

17 Apr 2014

Scientists to combine environmental, surveillance data to predict malaria outbreaks in Ethiopia

Dealing with malaria is a fact of life for more than 91 million Ethiopians. Each year four to five million contract malaria, one of the biggest health problems in this poor country.

16 Apr 2014

DEP awards nearly $2.1 million in West Nile Virus grants to 26 counties

The Department of Environmental Protection today announced it is awarding nearly $2.1 million in West Nile Virus (WNV) Control Program Grants to 26 counties.

16 Apr 2014

Pitt CVR and Sanofi Pasteur join forces to help assess effectiveness of dengue vaccine

The University of Pittsburgh Center for Vaccine Research (CVR) and Sanofi Pasteur, the vaccines division of Sanofi, have entered a scientific collaboration to help assess the effectiveness of a dengue vaccine once introduced for immunization programs.

16 Apr 2014

Researchers generate 3D model of human malaria parasite genome

A research team led by a cell biologist at the University of California, Riverside has generated a 3D model of the human malaria parasite genome at three different stages in the parasite's life cycle - the first time such 3D architecture has been generated during the progression of the life cycle of a parasite.

7 Apr 2014

Repellents from Greek herb extracts show potent effects against malaria carrying mosquitoes

Repellents derived from Greek herb extracts show potent effects, as spatial repellents, against malaria carrying mosquitoes, and possibly others.

4 Apr 2014

WHO to highlight increasing threat of vector-borne diseases on World Health Day 2014

More than half the world's population is at risk from diseases such as malaria, dengue, leishmaniasis, Lyme disease, schistosomiasis, and yellow fever, carried by mosquitoes, flies, ticks, water snails and other vectors. Every year, more than one billion people are infected and more than one million die from vector-borne diseases.

2 Apr 2014

Notre Dame biologists awarded $23M research grant to prevent malaria and dengue fever

Notre Dame biologists Nicole Achee and Neil Lobo are leaders of an international $23 million research grant from the Bill & Melinda Gates Foundation. Their five-year project will generate the data required to show the effectiveness of a new paradigm in mosquito control -spatial repellency - for the prevention of two important mosquito-borne diseases: malaria and dengue fever.

13 Mar 2014

Warmer temperatures allow malaria to spread to higher elevations

Malaria, a mosquito-borne disease, infects more than 300 million people each year. Cooler highland regions have historically provided havens from malaria, but it has been predicted that the disease could be especially sensitive to climate change, since both the Plasmodium parasites that cause it and the Anopheles mosquitoes that spread it thrive at warm temperatures. The potential impact of global warming on the worldwide incidence of malaria has been debated for more than two decades.

7 Mar 2014

Researchers discover new target for human antibodies that holds key to vaccine for dengue

Creating a vaccine that protects people from all four types of dengue virus has frustrated scientists for decades. But researchers at the University of North Carolina have discovered a new target for human antibodies that could hold the key to a vaccine for the world's most widespread mosquito-borne disease.

27 Feb 2014

Origin of deadly human malaria parasite linked to primates in Africa, not Asia

An international team of scientists has traced the origin of Plasmodium vivax, the second-worst malaria parasite of humans, to Africa, according to a study published this week in Nature Communications.

25 Feb 2014

Researchers find that single genetic mutation causes resistance to DDT and pyrethroids

Researchers from LSTM have found that a single genetic mutation causes resistance to DDT and pyrethroids (an insecticide class used in mosquito nets). With the continuing rise of resistance the research, published in the journal Genome Biology, is key as scientists say that this knowledge could help improve malaria control strategies.

25 Feb 2014

New research may provide insight on how dengue virus gains entry into cells

Dengue fever, an infectious tropical disease caused by a mosquito-borne virus, afflicts millions of people each year, causing fever, headache, muscle and joint pains and a characteristic skin rash. In some people the disease progresses to a severe, often fatal, form known as dengue hemorrhagic fever.

18 Feb 2014

Fraunhofer USA receives FDA clearance for IND malaria TBV that targets Pfs25 antigen

Fraunhofer USA Center for Molecular Biotechnology (FhCMB) announced today that clearance was obtained from the U.S. Food and Drug Administration (FDA) for an investigational new drug (IND), Fraunhofer's plant-derived malaria transmission-blocking vaccine (TBV), which targets the Pfs25 antigen, to proceed into the clinic in a Phase 1 safety and immunogenicity study.

5 Feb 2014

USF Health receives $2.1M grant to study on new factors required for growth of malaria-related parasites

Animal cells similar to those of humans contain a "control room," called the centrosome, which regulates cell replication. Disrupt this core hub and you kill cell division.

24 Jan 2014

Mosquito News and Research

Inovio announces positive results on DNA-based monoclonal antibody therapy targeting CHIKV

Researchers uncover potential vaccine that can stop malaria parasites from multiplying

NIH-funded study in tanzanian infants tracked risk of severe malaria over time

Biotech to the rescue

Johns Hopkins hosts World Malaria Day to combat malaria in Africa

Findings could revive use of chloroquine drug in treating, preventing mosquito-bourne disease

Scientists to combine environmental, surveillance data to predict malaria outbreaks in Ethiopia

DEP awards nearly $2.1 million in West Nile Virus grants to 26 counties

Pitt CVR and Sanofi Pasteur join forces to help assess effectiveness of dengue vaccine

Researchers generate 3D model of human malaria parasite genome

Repellents from Greek herb extracts show potent effects against malaria carrying mosquitoes

WHO to highlight increasing threat of vector-borne diseases on World Health Day 2014

Notre Dame biologists awarded $23M research grant to prevent malaria and dengue fever

Warmer temperatures allow malaria to spread to higher elevations

Researchers discover new target for human antibodies that holds key to vaccine for dengue

Origin of deadly human malaria parasite linked to primates in Africa, not Asia

Researchers find that single genetic mutation causes resistance to DDT and pyrethroids

New research may provide insight on how dengue virus gains entry into cells

Fraunhofer USA receives FDA clearance for IND malaria TBV that targets Pfs25 antigen

USF Health receives $2.1M grant to study on new factors required for growth of malaria-related parasites

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News